Your browser doesn't support javascript.
loading
miR-139-5p controls translation in myeloid leukemia through EIF4G2.
Emmrich, S; Engeland, F; El-Khatib, M; Henke, K; Obulkasim, A; Schöning, J; Katsman-Kuipers, J E; Michel Zwaan, C; Pich, A; Stary, J; Baruchel, A; de Haas, V; Reinhardt, D; Fornerod, M; van den Heuvel-Eibrink, M M; Klusmann, J H.
Afiliação
  • Emmrich S; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Engeland F; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • El-Khatib M; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Henke K; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Obulkasim A; Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Schöning J; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Katsman-Kuipers JE; Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Michel Zwaan C; Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Pich A; Institute for Toxicology, Hannover Medical School, Hannover, Germany.
  • Stary J; Department of Pediatric Hematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Baruchel A; Department of Hematology, Hopitaux universitaires Saint-Louis, St Louis Hospital, Paris, France.
  • de Haas V; Dutch Childhood Oncology Group (DCOG), Stichting Kinderoncologie Nederland (SKION), Hague, The Netherlands.
  • Reinhardt D; Clinic for Pediatrics III, University Hospital Essen, Essen, Germany.
  • Fornerod M; Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.
  • van den Heuvel-Eibrink MM; Department of Biochemistry, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Klusmann JH; Department of Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands.
Oncogene ; 35(14): 1822-31, 2016 Apr 07.
Article em En | MEDLINE | ID: mdl-26165837
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biossíntese de Proteínas / Leucemia Mieloide / Fator de Iniciação Eucariótico 4G / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biossíntese de Proteínas / Leucemia Mieloide / Fator de Iniciação Eucariótico 4G / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Oncogene Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha